Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

All

News

Sport

Culture

Lifestyle

The one surprising impact of weight loss jab Ozempic

New research indicates that weight-loss medications, specifically GLP-1RA drugs, may alleviate migraine pain and reduce asthma symptoms.

A study presented at the European Congress On Obesity found that women using Wegovy for weight management experienced a 7 per cent reduction in prescriptions for triptan-class migraine medication.

Separately, another study revealed that individuals prescribed GLP-1 drugs for obesity or type 2 diabetes saw a 26 per cent fall in asthma exacerbations and a 14 per cent drop in reliever inhaler use.

Experts suggest that the weight loss achieved with these medications is a significant factor, as it reduces the pro-inflammatory state linked to excess fatty tissue.

These findings contribute to a growing body of evidence highlighting the potential therapeutic benefits of GLP-1RA…